Kitchen, P., Lee, K. Y., Clark, D., Lau, N., Lertsuwan, J., Sawasdichai, A., . . . Jayaraman, P. S. (2020). A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition. Cancer Res, 80(4), 757-770. doi:10.1158/0008-5472.CAN-19-0942

14 Feb 2020
0
0

Kitchen, P., Lee, K. Y., Clark, D., Lau, N., Lertsuwan, J., Sawasdichai, A., . . . Jayaraman, P. S. (2020). A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition. Cancer Res, 80(4), 757-770. doi:10.1158/0008-5472.CAN-19-0942

Tags

Share this

Related Posts

Hyaluronidase inhibitors (sodium cromoglycate and sodium auro-thiomalate) reduce the local tissue damage and prolong the survival time of mice injected with Naja kaouthia and Calloselasma rhodostoma venoms. Yingprasertchai S, Bunyasrisawat S, Ratanabanangkoon K Toxicon42p635-46(2003 Nov)
28 Nov 2003
0

Hyaluronidase inhibitors (sodium cromoglycate and sodium auro-thiomalate) reduce the local tissue damage and prolong the survival time of mice injected with Naja kaouthia and Calloselasma rhodostoma venoms. Yingprasertchai S, Bunyasrisawat S, Ratanabanangkoon K Toxicon42p635-46(2003 Nov)

Hyaluronidase inhibitors (sodium cromoglycate and sodium auro-thiomalate) reduce the local tissue damage and prolong the survival time of mice injected with Naja kaouthia and Calloselasma rhodostoma venoms. Yingprasertchai S, Bunyasrisawat S, Ratanabanangkoon K Toxicon42p635-46(2003 Nov)
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More